Cryptococcal Antigen Lateral Flow Assay Test Market
The cryptococcal antigen lateral flow assay is a type of an immunochromotography test system, used to identify the capsular polysaccharide antigens of cryptococcus species present in serum and Cerebrospinal Fluid (CSF). The combinational use of immunoassay and chromatography has made revolutionary changes in the point of care diagnosis of cryptococcal fungi. The patient are allowing to monitor the presence of fungal infection through one strip of lateral flow assay test. These test are gaining popularity across major developed countries of North America and Europe, owing to their simple operating procedure as compared to other assay techniques. Moreover, the high accuracy and sensitivity with least lead time to produce outcome are providing opportunities for early stage development products.
The cryptococcal antigen lateral flow assay is a type of an immunochromotography test system, used to identify the capsular polysaccharide antigens of cryptococcus species present in serum and Cerebrospinal Fluid (CSF). The combinational use of immunoassay and chromatography has made revolutionary changes in the point of care diagnosis of cryptococcal fungi. The patient are allowing to monitor the presence of fungal infection through one strip of lateral flow assay test. These test are gaining popularity across major developed countries of North America and Europe, owing to their simple operating procedure as compared to other assay techniques. Moreover, the high accuracy and sensitivity with least lead time to produce outcome are providing opportunities for early stage development products.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Report Description<br />
<strong>Cryptococcal</strong> <strong>Antigen</strong> <strong>Lateral</strong> <strong>Flow</strong> <strong>Assay</strong> <strong>Test</strong> <strong>Market</strong>: Region-wise Outlook<br />
Based on geography, the cryptococcal antigen lateral flow assay test market is segmented<br />
into North America, Europe, Asia Pacific, and MEA. The commercial success of<br />
<strong>Cryptococcal</strong> <strong>Antigen</strong> <strong>Lateral</strong> <strong>Flow</strong> <strong>Assay</strong> <strong>Test</strong> would benefit the African countries,<br />
especially in sub-Saharan Africa owing to higher incidence rate of cryptococcosis<br />
infections. Hence, the <strong>Cryptococcal</strong> <strong>Antigen</strong> <strong>Lateral</strong> <strong>Flow</strong> <strong>Assay</strong> <strong>Test</strong> <strong>Market</strong> would witness<br />
attractive demand from the middle and African countries, followed by Asia Pacific region.<br />
The developed regions are the early adopter of this technology and hence, would<br />
represent healthy market share in 2015.<br />
<strong>Cryptococcal</strong> <strong>Antigen</strong> <strong>Lateral</strong> <strong>Flow</strong> <strong>Assay</strong> <strong>Test</strong> <strong>Market</strong>: Key Players<br />
Key players profiled in this report includes, Kestrel Biosciences LIC, Alere, Inc.,<br />
BioMerieux, Danaher Corporation, Forsite Diagnostics, Merck Millipore, Qiagen, Roche<br />
Diagnostics, Hologic (Gen-Probe), and Siemens Healthcare. These players are focusing<br />
oin the development more advanced and more convenient instrument to cater the<br />
need to point of care testing and home healthcare testing application.
Change language